UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(MARK ONE)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarter ended ~~September~~March 3031, ~~2025~~2026

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-43007

BLUEROCK ACQUISITION CORP.

(Exact Name of Registrant as Specified in Its Charter)

Cayman Islands		N/A
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

919 Third Avenue

New York, New York

10022

(Address of principal executive offices)

(Zip Code)

(212) 843-1601

(Issuer’s telephone number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant	BLRKU	The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share	BLRK	The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share	BLRKW	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐☒ No ☒☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of ~~January~~May 2614, 2026, there were 17,250,000 Class A ordinary shares, par value $0.0001 par share, issued and outstanding, and 5,750,000 Class B ordinary shares, par value $0.0001 per share, issued and outstanding.

BLUEROCK ACQUISITION CORP.

FORM 10-Q FOR THE QUARTER ENDED ~~SEPTEMBER~~MARCH 3031, ~~2025~~ 2026

TABLE OF CONTENTS

		Page
Part I. Financial Information
Item 1. Interim Financial Statements		1
Condensed Balance Sheet as of September 30, 2025 (Unaudited)		1
Condensed Balance Sheets as of March 31, 2026 (Unaudited) and December 31, 2025		1
Condensed Statement of Operations for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited)		2
Condensed Statement of Operations for the Three Months Ended March 31, 2026 (Unaudited)		2
Condensed Statement of Changes in Shareholder’s Deficit for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited)		3
Condensed Statement of Changes in Shareholders’ Deficit for the Three Months Ended March 31, 2026 (Unaudited)		3
Condensed Statement of Cash Flows for the Period from July 11, 2025 (Inception) Through September 30, 2025 (Unaudited)		4
Condensed Statement of Cash Flows for the Three Months Ended March 31, 2026 (Unaudited)		4
Notes to Condensed Financial Statements (Unaudited)		5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		1617
Item 3. Quantitative and Qualitative Disclosures About Market Risk		1820
Item 4. Controls and Procedures		1820
Part II. Other Information
Item 1. Legal Proceedings		1921
Item 1A. Risk Factors		1921
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		1921
Item 3. Defaults Upon Senior Securities		1921
Item 4. Mine Safety Disclosures		1921
Item 5. Other Information		1921
Item 6. Exhibits		2021
Part III. Signatures		2122

PART I - FINANCIAL INFORMATION

Item 1. Interim Financial Statements.

BLUEROCK ACQUISITION CORP.

CONDENSED BALANCE ~~SHEET~~SHEETS

SEPTEMBER 30, 2025

	March 31,			December 31,
	2026			2025
	(Unaudited)

Assets
Current assets
Cash	$	497,651		$	693,561
Prepaid insurance		66,500			66,500
Prepaid expenses		75,576			21,333
Total current assets		639,727			781,394
Long-term prepaid insurance		47,104			63,729
Cash and marketable securities held in Trust Account		174,208,247			172,738,674
Total Assets	$	174,895,078		$	173,583,797

Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit
Current liabilities
Accrued offering costs	$	75,000		$	75,000
Accrued expenses		55,077			4,617
Total current liabilities		130,077			79,617
Deferred underwriting fee		7,350,000			7,350,000
Total Liabilities		7,480,077			7,429,617

Commitments (Note 6)
Class A ordinary shares subject to possible redemption, $0.0001 par value; 17,250,000 shares at redemption value of $10.10 and $10.01 per share as of March 31, 2026 and December 31, 2025, respectively		174,208,247			172,738,674

Shareholders’ Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding as of March 31, 2026 and December 31, 2025		—			—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding (excluding 17,250,000 shares subject to possible redemption) as of March 31, 2026 and December 31, 2025		—			—
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025 ⁽¹⁾		575			575
Additional paid-in capital		—			—
Accumulated deficit		(6,793,821	)		(6,585,069	)
Total Shareholders’ Deficit		(6,793,246	)		(6,584,494	)
Total Liabilities, Class A Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit	$	174,895,078		$	173,583,797

(~~UNAUDITED~~1) Includes up to 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On December 12, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 750,000 Founder Shares are no longer subject to forfeiture (Note 7).

Assets
Current assets
Cash	$	249,101
Total current assets		249,101
Deferred offering costs		322,564
Total Assets	$	571,665
Liabilities and Shareholder’s Deficit
Current liabilities
Accrued offering costs	$	289,565
Accrued expenses		6,603
Promissory note – related party		300,000
Total Current Liabilities		596,168
Commitments (Note 6)
Shareholder’s Deficit
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued or outstanding		—
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; none issued or outstanding		—
Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 5,750,000 shares issued and outstanding (1)(2)		575
Additional paid-in capital		24,425
Accumulated deficit		(49,503	)
Total Shareholder’s Deficit		(24,503	)
Total Liabilities and Shareholder’s Deficit	$	571,665

(1)

On October 1, 2025, the Sponsor surrendered 1,916,667 Founder Shares to the Company for no consideration, resulting in the Sponsor holding 5,750,000 Founder Shares (see Note 5). All share and per share data have been retrospectively presented.

(2)

Includes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On December 12, 2025, the Company consummated its Initial Public Offering and sold 17,250,000 Units, including 2,250,000 Units sold pursuant to the exercise of the underwriters’ option in full to purchase additional units to cover the over-allotment; hence, the 750,000 Class B ordinary shares are no longer subject to forfeiture.

The accompanying notes are an integral part of the unaudited condensed financial statements.

BLUEROCK ACQUISITION CORP.

CONDENSED STATEMENT OF OPERATIONS

FOR THE ~~PERIOD~~THREE ~~FROM~~MONTHS ~~JULY~~ENDED ~~11,~~MARCH ~~2025 (INCEPTION) THROUGH SEPTEMBER 30~~31, ~~2025~~ 2026

(UNAUDITED)

General and administrative costs	$	49208,~~503~~752
Loss from operations		(49208,~~503~~752	)
Net loss	$	(49,503	)
Other income:
Weighted average shares outstanding, Class B ordinary shares (1)(2)		5,000,000
Interest earned on cash and marketable securities held in Trust Account		1,469,573
Basic and diluted net loss per share, Class B ordinary shares	$	(0.01	)
Total other income		1,469,573
Net income	$	1,260,821
Basic and diluted weighted average shares outstanding, Class A ordinary shares		17,250,000
Basic and diluted net income per share, Class A ordinary shares	$	0.05
Basic and diluted weighted average shares outstanding, Class B ordinary shares		5,750,000
Basic and diluted net income per share, Class B ordinary shares	$	0.05

(1)

(2)

Excludes an aggregate of up to 750,000 Class B ordinary shares that were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (see Note 5). On December 12, 2025, the Company consummated its Initial Public Offering and sold 17,250,000 Units, including 2,250,000 Units sold pursuant to the exercise of the underwriters’ option in full to purchase additional units to cover the over-allotment; hence, the 750,000 Class B ordinary shares are no longer subject to forfeiture.

The accompanying notes are an integral part of the unaudited condensed financial statements.

BLUEROCK ACQUISITION CORP.

CONDENSED STATEMENT OF CHANGES IN ~~SHAREHOLDER~~SHAREHOLDERS’S DEFICIT

FOR THE ~~PERIOD~~THREE ~~FROM~~MONTHS ~~JULY~~ENDED ~~11,~~MARCH ~~2025 (INCEPTION) THROUGH SEPTEMBER 30~~31, ~~2025~~2026

(UNAUDITED)

	Class A Ordinary Shares				Class B Ordinary Shares				Additional Paid-in		Accumulated			Total ~~Shareholder~~Shareholders’s
	Shares		Amount		Shares		Amount		Capital		Deficit			Deficit
Balance — July 11, 2025 (inception)		—	$	—		—	$	—	$	—	$	—		$	—
Balance – December 31, 2025		—	$	—		5,750,000	$	575	$	—	$	(6,585,069	)	$	(6,584,494	)
Issuance of Class B ordinary shares to Sponsor (1)(2)		—		—		5,750,000		575		24,425		—			25,000
Accretion for Class A ordinary shares to redemption amount		—		—		—		—		—		(1,469,573	)		(1,469,573	)
Net loss		—		—		—		—		—		(49,503	)		(49,503	)
Net income		—		—		—		—		—		1,260,821			1,260,821
Balance – September 30, 2025		—	$	—		5,750,000	$	575	$	24,425	$	(49,503	)	$	(24,503	)
Balance – March 31, 2026 (unaudited)		—	$	—		5,750,000	$	575	$	—	$	(6,793,821	)	$	(6,793,246	)

(1)

(2)

The accompanying notes are an integral part of the unaudited condensed financial statements.

BLUEROCK ACQUISITION CORP.

CONDENSED STATEMENT OF CASH FLOWS

FOR THE ~~PERIOD~~THREE ~~FROM~~MONTHS ~~JULY~~ENDED ~~11,~~MARCH ~~2025 (INCEPTION) THROUGH SEPTEMBER 30~~31, ~~2025~~ 2026

(UNAUDITED)

Cash Flows from Operating Activities:
Net loss	$	(49,503	)
Net income	$	1,260,821
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to reconcile net income to net cash used in operating activities:
Payment of general and administrative costs through promissory note – related party		42,900
Interest earned on cash and marketable securities held in Trust Account		(1,469,573	)
Changes in operating assets and liabilities:
Accrued expenses		6,603
Prepaid expenses		(54,243	)
Net cash used in operating activities		—
Long-term prepaid insurance		16,625
Cash Flows from Financing Activities:
Accrued expenses		50,460
Proceeds from promissory note – related party		249,101
Net cash used in operating activities		(195,910	)
Net cash provided by financing activities		249,101
Net Change in Cash		(195,910	)
Net Change in Cash		249,101
Cash – Beginning of period		693,561
Cash – Beginning of period		—
Cash – End of period	$	497,651
Cash – End of period	$	249,101
Noncash investing and financing activities:
Deferred offering costs included in accrued offering costs	$	289,565
Deferred offering costs paid through promissory note – related party	$	7,999
Deferred offering costs paid by the Sponsor in exchange for issuance of Class B ordinary shares	$	25,000

The accompanying notes are an integral part of the unaudited condensed financial statements.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

Bluerock Acquisition Corp. (the “Company”) is a blank check company incorporated in the Cayman Islands on July 11, 2025. The Company was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.

As of ~~September~~March 3031, ~~2025~~2026, the Company had not commenced any operations. All activity for the period from July 11, 2025 (inception) through ~~September~~March 3031, ~~2025~~2026 relates to the Company’s formation, ~~and~~ the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The registration statement for the Company’s Initial Public Offering became effective on December 10, 2025. On December 12, 2025, the Company consummated the Initial Public Offering of 17,250,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which includes the full exercise by the underwriters of their over-allotment option ~~in full~~ of 2,250,000 Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 4,500,000 warrants (the “Private Placement Warrants”), at a price of $1.00 per Private Placement Warrant, in a private placement to Bluerock Acquisition Holdings LLC (the “Sponsor”) and Cantor Fitzgerald & Co., the representative of the underwriters of the Initial Public Offering ~~(the “Representative”)~~, generating gross proceeds of $4,500,000. Of those 4,500,000 Private Placement Warrants, the Sponsor purchased 3,000,000 Private Placement Warrants and ~~the~~Cantor ~~Representative~~ purchased 1,500,000 Private Placement Warrants. Each whole Private Placement Warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. The Private Placement Warrants will become exercisable 30 days after the completion of the initial Business Combination.

Transaction costs amounted to $10,960,469, consisting of $3,000,000 of cash underwriting fee, $7,350,000 of deferred underwriting fee and $610,469 of other offering costs.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete a Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the value of the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes paid or payable on the interest earned on the Trust Account) on the date of the execution of a definitive agreement into an initial Business Combination. The Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”).

Following the closing of the Initial Public Offering on December 12, 2025, an amount of $172,500,000 ($10.00 per Unit) from the net proceeds of the sale of the Units, and a portion of the net proceeds from the sale of the Private Placement Warrants, was held in a trust account (“Trust Account”), located in the United States and invested only in U.S. government treasury obligations with a maturity of 185 days or less, in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act, which invest only in direct U.S. government treasury obligations and/or held as cash or cash items (including in demand deposit accounts), until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the funds held in the Trust Account, as described below.

The Company will provide its holders of the outstanding Public Shares (the “public shareholders”) with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would require the Company to seek shareholder approval under applicable law or stock exchange listing requirements. The public shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000 of interest to pay liquidation expenses). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s warrants. The Public Shares subject to redemption will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, Distinguishing Liabilities from Equity ~~(“FASB ASC 480”)~~.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

The Company will proceed with a Business Combination only if the majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its second amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (the “SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each public shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or ~~don’t~~do not vote at all.

Notwithstanding the above, if the Company seeks shareholder approval of a Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provides that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% or more of the Public Shares, without the prior consent of the Company.

The initial shareholders have agreed to waive their redemption rights with respect to any Founder Shares (as defined in Note 5) held and any Public Shares they may acquire during or after the Initial Public Offering in connection with the completion of Business Combination, except that Public Shares held by the initial shareholders will be subject to mandatory redemption upon any diminution of the Trust Account in connection with an extension, and such shares will be entitled to redemption at a price equal to the per -share redemption value then held in the Trust Account in connection therewith.

The Company will have until 24 months from the closing of the Initial Public Offering to complete a Business Combination. However, if the Company anticipates that it may not be able to consummate a Business Combination within 24 months from the closing of the Initial Public Offering, the Company may, but is not obligated to, by resolution of the board if requested by the initial shareholders, extend the period of time to consummate a Business Combination the Company may seek shareholder approval to amend the Amended and Restated Memorandum and Articles of Association to extend the date by which the Company must consummate the initial Business Combination. If the Company seeks shareholder approval for an extension, holders of Public Shares will be offered an opportunity to redeem their shares, regardless of whether they abstain, vote for, or against, the Company’s initial Business Combination, at a per -share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned thereon (which interest shall be net of taxes paid or payable (excluding any 1% U.S. federal excise tax on ~~share~~stock repurchases under the Inflation Reduction Act of 2022, or similar tax, that is imposed on the Company, if any) and up to $100,000 of interest to pay liquidation expenses) and not previously released to the Company pursuant to permitted withdrawals, divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law. For the avoidance of doubt, the time to complete a Business Combination shall not be extended beyond 24 months without a shareholder vote. The underwriters have agreed to waive their rights to their deferred underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within (i) the period ending on the date that is 24 months from the closing of the Initial Public Offering, or such earlier liquidation date as its board of directors may approve, in which it must complete an initial Business Combination or (ii) such other time period in which the Company must complete an initial Business Combination pursuant to an amendment to its Amended and Restated Memorandum and Articles of Association (the “Completion Window”) and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares.

In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement (except for the Company’s independent registered public accounting firm), reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the trust assets, less taxes paid or payable and up to $100,000 of interest to pay liquidation expenses, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

NOTE 2. SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the period presented.

The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s ~~final~~Annual ~~prospectus~~Report ~~for~~on ~~its~~Form ~~Initial~~10-K ~~Public~~for ~~Offering as filed with~~ the ~~SEC~~period onfrom ~~December~~July 1211, 2025, as(inception) ~~well~~to asDecember ~~the~~31, ~~Company’s Current Report on Form 8-K~~2025, as filed with the SEC on ~~December~~March 1820, ~~2025~~2026 (the “Annual Report”). The interim results for the ~~period~~three ~~from~~months ~~July~~ended ~~11,~~March ~~2025 (inception) through September 30~~31, ~~2025~~2026, are not necessarily indicative of the results to be expected for the period ending December 31, ~~2025~~2026 or for any future periods.

Liquidity and Capital Resources

The Company’s liquidity needs up tountil ~~September~~the ~~30,~~Initial ~~2025~~Public Offering had been satisfied through the loan under an unsecured promissory note from the Sponsor of up to $300,000 (see Note 5). As of ~~September~~March 3031, ~~2025~~2026, the Company had $~~249~~497,~~101~~651 of cash and had a working capital ~~deficit~~surplus of $~~347~~509,~~067~~650.

In order to finance transaction costs in connection with the initial Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes the initial Business Combination, the Company will repay such loaned amounts. In the event that the initial Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, including the repayment of loans from the Sponsor to pay for any amount deposited to pay for any extension of the time to complete the initial Business Combination, but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into ~~warrants~~Warrants, at a price of $1.00 per warrant at the option of the lender, upon consummation of the initial Business Combination. The ~~warrants~~Warrants would be identical to the Private Placement Warrants. The terms of such loans by the Company’s officers and directors, if any, have not been determined and no written agreements exist with respect to such loans. There are no such outstanding related party loans as of ~~September~~March 3031, ~~2025~~2026.

In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC ~~204~~205-5040, Presentation of Financial Statements - Going Concern, the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. The Company has the Completion Window to complete the initial Business Combination. Management has determined that ~~upon~~ the ~~consummation of the Initial Public Offering, the~~ Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the ~~unaudited condensed~~ financial ~~statements~~statement. The Company consummated its Initial Public Offering on December 12, 2025, generating gross proceeds of $172,500,000 and the simultaneous sale of Private Placement Warrants, generating gross proceeds of $4,500,000. As a result, the Company has $879,728 in cash and $790,828 of working capital as of December 12, 2025.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As such, the Company is eligible to take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates

The preparation of the unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities ~~and the reported amounts of expenses during the reporting period~~.

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ from those estimates.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $~~249~~497,~~101~~651 and $693,561 in cash and no cash equivalents as of ~~September~~March 3031, 2026 and December 31, 2025, respectively.

Cash and Marketable Securities Held in Trust Account

As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account, amounting to $174,208,247 and $172,738,674, respectively, were held in cash and marketable securities invested in U.S. Treasury funds.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

~~Deferred~~ Offering Costs

The Company complies with the requirements of FASB ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A, Expenses of Offering. ~~Deferred~~Offering ~~offering~~ costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, Debt with Conversion and Other Options, addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the warrants and ~~then~~ to the Class A ordinary shares. ~~On December 12, 2025, upon the closing of the Initial Public~~ Offering, ~~offering~~ costs allocated to the Public Shares were charged to temporary equity, and offering costs allocated to the Public and Private Placement Warrants were charged to shareholders’ deficit as Public and Private Placement Warrants, after management’s evaluation, were accounted for under equity treatment.

Income Taxes

The Company accounts for income taxes under FASB ASC 740, Income Taxes (“~~FASB~~ ASC 740”). FASB ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial ~~statement~~statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carryforwards. FASB ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

FASB ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. FASB ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s unaudited condensed financial statements. Since the Company was incorporated on July 11, 2025, the evaluation was performed for the upcoming ~~2025~~2026 tax year which will be the only period subject to examination.

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There are no taxes in the Cayman Islands, and accordingly, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of March 31, 2026 and December 31, 2025. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There are no taxes in the Cayman Islands, and accordingly, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements.

Class A Ordinary Shares Subject to Possible Redemption

The Public Shares contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation, or if there is a shareholder vote or tender offer in connection with the Company’s initial Business Combination. In accordance with FASB ASC 480-10-S99, the Company classifies Public Shares subject to redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and then to accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets. As of March 31, 2026 and December 31, 2025, the Class A ordinary shares subject to possible redemption reflected in the condensed balance sheets are reconciled in the following table:

Gross proceeds	$	172,500,000
Less:
Proceeds allocated to Public Warrants		(2,254,000	)
Public Shares issuance cost		(10,801,935	)
Plus:
Remeasurement of carrying value to redemption value		13,294,609
Class A ordinary shares subject to possible redemption, December 31, 2025	$	172,738,674
Plus:
Accretion of carrying value to redemption value		1,469,573
Class A ordinary shares subject to possible redemption, March 31, 2026	$	174,208,247

Net Income per Ordinary Share

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net income per ordinary share is computed by dividing net income by the weighted average number of shares of ordinary shares outstanding for the period. The Company has two classes of ordinary shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Accretion associated with the redeemable shares of Class A ordinary shares is excluded from income per ordinary share as the redemption value approximates fair value.

The following table reflects the calculation of basic and diluted net income per ordinary share (in dollars, except per-share amounts):

	For the Three Months Ended March 31, 2026
	Class A		Class B
Basic and diluted net income per ordinary share
Basic and diluted net income per ordinary share
Numerator:
Allocation of net income	$	945,616	$	315,205
Denominator:
Basic weighted average shares outstanding		17,250,000		5,750,000
Basic net income per ordinary share	$	0.05	$	0.05

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

MARCH 31, 2026

(UNAUDITED)

Fair Value of Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC Topic 820, Fair Value Measurement, approximates the carrying amounts represented in the accompanying ~~unaudited~~ condensed balance ~~sheet~~sheets, primarily due to their short-term nature.

Warrants

The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC Topic 480, ~~and~~Distinguishing ~~FASB~~Liabilities from Equity (“ASC ~~Topic 815~~480”), ~~Derivatives~~ and ~~Hedging (“~~FASB ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to FASB ASC 480, meet the definition of a liability pursuant to FASB ASC 480, and whether the warrants meet all of the requirements for equity classification under FASB ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

For issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component of additional paid-in capital at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter. Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the condensed statement of operations.

The warrants are not precluded from equity classification and were accounted for as such on the date of issuance and each balance sheet date thereafter. There are no5,750,000 ~~outstanding~~ Public Warrants and 4,500,000 Private Placement Warrants currently outstanding as of ~~September~~March 3031, 2026 and December 31, 2025.

Share-Based Compensation

The Company records share-based compensation in accordance with FASB ASC Topic 718, Compensation-Stock Compensation (“~~FASB~~ ASC 718”), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued using the Monte Carlo model. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the condensed statement of operations. Share-based compensation expense was not recognized during the period presented as the consummation of a business combination was not considered probable as of the reporting date.

Net Loss per Class B Ordinary Share

Net loss per Class B ordinary share is computed by dividing net loss by the weighted average number of Class B ordinary shares issued and outstanding during the period. Weighted average shares were reduced for the effect of an aggregate of 750,000 Class B ordinary shares that were subject to forfeiture if the over-allotment option was not exercised by the underwriters (see Note 5). At September 30, 2025, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per Class B ordinary share is the same as basic loss per Class B ordinary share for the period presented.

Recent Accounting Standards

Management does not believe that any ~~other~~ recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3. INITIAL PUBLIC OFFERING

Pursuant to the ~~consummation~~closing of the Initial Public Offering on December 12, 2025, the Company sold 17,250,000 Units, including 2,250,000 Units for the ~~exercise~~full close of the underwriters’ overallotment option ~~in full~~, at a purchase price of $10.00 per Unit, generating gross proceeds of $172,500,000. Each Unit consists of one Class A ordinary share and one-third of one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).

9NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering on December 12, 2025, the Sponsor and the underwriters purchased 4,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $4,500,000. Of those 4,500,000 Private Placement Warrants, the Sponsor purchased 3,000,000 Private Placement Warrants and Cantor purchased 1,500,000 Private Placement Warrants. If the Company does not complete a Business Combination, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

NOTE 4. PRIVATE PLACEMENT

Simultaneously with the closing of the Initial Public Offering on December 12, 2025, the Sponsor and the underwriters purchased 4,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $4,500,000. Of those 4,500,000 Private Placement Warrants, the Sponsor purchased 3,000,000 Private Placement Warrants and the Representative purchased 1,500,000 Private Placement Warrants. If the Company does not complete a Business Combination, the proceeds from the sale of the Private Placement Warrants held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law) and the Private Placement Warrants will expire worthless.

NOTE 5. RELATED PARTY TRANSACTIONS

Founder Shares

On July 23, 2025, the Sponsor was issued 7,666,667 Class B ordinary shares (the “Founder Shares”) for an aggregate price of $25,000, or approximately $0.003 per share, paid to cover certain expenses on behalf of the Company. On October 1, 2025, the Sponsor surrendered 1,916,667 Founder Shares ~~to the Company~~ for no consideration. On October 29, 2025, the Sponsor transferred 60,000 Founder Shares to the independent directors, resulting in the Sponsor holding 5,690,000 of the total 5,750,000 Founder Shares. All share and per -share data have been retrospectively presented. The Founder Shares include an aggregate of up to 750,000 ~~Founder~~Class B ~~Shares~~ordinary shares that ~~are~~were subject to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment option iswas not exercised in full or in part, so that the Sponsor ~~will~~would own, on an as-converted basis, 25% of the Company’s issued and outstanding shares after the Initial Public Offering. On December 12, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, the 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor.

On October 29, 2025, the Sponsor assigned and transferred an aggregate of 60,000 Founder Shares to the two independent directors of the Company in exchange for their services as independent directors through the Company’s initial Business Combination. The Founder Shares will remain with the Sponsor if the independent directors are no longer serving the Company prior to the initial Business Combination. The Founder Share transfer is within the scope of FASB ASC 718. Under FASB ASC 718, stock-based compensation associated with equity classified awards is measured at fair value upon the assignment date. The total fair value of the 60,000 Founder Shares on October 29, 2025 was $187,140 or $3.12 per share. The Company established the initial fair value of the Founder Shares on October 29, 2025, the date of the grant agreement, using a calculation prepared by a third- party valuation team which takes into consideration a risk-free rate of 3.95%, implied market adjustment of 31.7%, and underlying stock price of $9.87. The Founder Shares were assigned subject to a performance condition (i.e., providing services through Business Combination). Stock-based compensation would be recognized at the date a Business Combination is considered probable (i.e., upon consummation of a Business Combination) in an amount equal to the number of Founder Shares times the assignment date fair value per share (unless subsequently modified) less the amount initially received for the assignment of the Founder Shares. As of ~~September~~March 3031, ~~2025~~2026, ~~prior to~~ the ~~date of assignment and transfer of Founder Shares, the~~ Company determined that the initial Business Combination is not considered probable and therefore no compensation expense has been recognized.

The Founder Shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in the Units sold in the Initial Public Offering, and holders of Founder Shares have the same shareholder rights as public shareholders, except that (i) the Founder Shares are subject to certain transfer restrictions, as described in more detail below, (ii) the Founder Shares are entitled to registration rights, (iii) in connection with their receipt of Founder Shares and/or Private Placement Warrants and their appointment as directors and/or officers, as applicable, the Company’s Sponsor, officers and directors have entered into a letter agreement with the Company, ~~dated December 10, 2025,~~ pursuant to which they have agreed, for no additional consideration, to (A) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with the completion of the Company’s initial Business Combination, (B) waive their redemption rights with respect to their Founder Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Company’s ~~amended~~Amended and ~~restated~~Restated ~~memorandum~~Memorandum and ~~articles~~Articles of ~~association~~Association (1) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Company’s Public Shares if the Company has not consummated an initial Business Combination within the completion window or (2) with respect to any other material provisions relating to shareholders’ rights or pre-initial Business Combination activity, (C3) waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares if the Company fails to complete the Company’s initial Business Combination within the completion window, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within such time period and to liquidating distributions from assets outside the Trust Account and (D4) vote any Founder Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination, (iv) the Founder Shares are automatically convertible into Class A ordinary shares immediately prior to, concurrently with or immediately following the consummation of the Company’s initial Business Combination or at any time prior thereto at the option of the holder on a one-for-one basis, subject to adjustment as described herein and in the ~~amended~~Amended and ~~restated~~Restated ~~memorandum~~Memorandum and ~~articles~~Articles of ~~association~~Association, and (v) prior to the closing of the Company’s initial Business Combination, only holders of Class B ordinary shares will be entitled to vote on the appointment and removal of directors or continuing in a jurisdiction outside the Cayman Islands (including any special resolution required to amend the constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation into a jurisdiction outside the Cayman Islands).

1011

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

The Founder Shares will automatically convert into Class A ordinary shares immediately prior to, concurrently with or immediately following the consummation of the initial ~~business~~Business ~~combination~~Combination or at any time prior thereto at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial ~~business~~Business ~~combination~~Combination, the ratio at which Class B ordinary shares convert into Class A ordinary shares will be adjusted (unless the holders of a majority of the outstanding Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares issuable upon conversion of all Class B ordinary shares will equal, in the aggregate, 25% of the sum of (i) the total number of all Class A ordinary shares outstanding upon the completion of the Initial Public Offering (including any Class A ordinary shares issued pursuant to the underwriters’ over-allotment option and excluding the Class A ordinary shares underlying the Private Placement Warrants issued to the Sponsor and ~~the Representative~~Cantor), plus (ii) all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the Company’s initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent warrants issued to the Company’s Sponsor or any of its affiliates or to the Company’s officers and directors upon conversion of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders in connection with an initial Business Combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis.

With certain limited exceptions, the Founder Shares are not transferable, assignable or saleable (except to the Company’s officers and directors and other persons or entities affiliated with the Company’s Sponsor, each of whom will be subject to the same transfer restrictions) until the earlier of (A) 180 days after the completion of the Company’s initial Business Combination or earlier if, subsequent to the initial Business Combination, the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share ~~sub-divisions~~subdivisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the closing of the initial Business Combination, and (B) the date following the completion of the Company’s initial Business Combination on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property. Up to 750,000 Founder Shares will be surrendered to the Company for no consideration depending on the exercise of the over-allotment option.

Promissory Note — Related Party

On July 23, 2025, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Promissory Note”). This loan was non-interest bearing and payable on the earlier of December 31, 2025 or the date on which the Company consummates the Initial Public Offering of its securities. AsOn ofDecember ~~September 30~~12, 2025, the Company had borrowed $300,000 ~~outstanding~~ under the Promissory Note which was fully settled ~~on December 12, 2025,~~ simultaneously with the closing of the Initial Public Offering. Borrowing against the Promissory Note is no longer available.

Administrative ~~Services~~Support ~~and Indemnification~~ Agreement

The Company’s Sponsor agreed, commencing on December 10, 2025, the effective date of the Initial Public Offering, through the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain general and administrative services, including office space, utilities and administrative services, as the Company may require from time to time. The Company has agreed to pay to the Sponsor $20,000 per month for up to twelve months during the 24-month period to complete a Business Combination. Upon completion of the initial Business Combination or liquidation, the Company will cease paying these monthly fees. AsFor ofthe ~~September~~three ~~30,~~months ~~2025,~~ended ~~such~~March ~~arrangements~~31, ~~had~~2026, ~~not~~the ~~been~~Company ~~executed~~incurred and ~~Company~~paid ~~did~~$60,000 ~~not~~in ~~incur any~~ fees for these services.

Related Party Loans

1112

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

NOTE 6. COMMITMENTS

Registration ~~and Shareholder~~ Rights Agreement

The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the Initial Public Offering, (ii) Private Placement Warrants which ~~will~~were be issued in a private placement simultaneously with the closing the Initial Public Offering and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of working capital loans, ~~will~~ have registration rights to require the Company to register a sale of any of the Company’s securities held by them and any other securities of the company acquired by them prior to the consummation of the Company’s initial Business Combination pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to the Company’s completion of the Company’s initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

Pursuant to the underwriting agreement dated December 1012, 2025, the Sponsor and the executive officers and directors have agreed that, for a period of 180 days from the date of the Initial Public Offering, they will not, without the prior written consent of the representative, offer, sell, contract to sell, pledge, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend or otherwise transfer or dispose of, directly or indirectly, any units, warrants, ordinary shares or any other securities convertible into, or exercisable or exchangeable for, any ~~Units~~units, ordinary shares, Founder Shares or warrants, subject to certain exceptions. The representative in its discretion may release any of the securities subject to these lock-up agreements at any time without notice, other than in the case of the officers and directors, which shall be with notice. The Sponsor, officers and directors are also subject to separate transfer restrictions on their Founder Shares and Private Placement Warrants pursuant to the letter agreement described herein.

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On December 12, 2025, the underwriters exercised their over-allotment option ~~in full~~, closing on the 2,250,000 additional units simultaneously with the Initial Public Offering.

The underwriters were paid in cash an underwriting discount of $3,000,000 ~~upon~~simultaneously at the closing of the Initial Public Offering ~~on December 12, 2025~~. In addition, the underwriters are entitled to a deferred fee of $0.60 per Unit, or $7,350,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination.

NOTE 7. ~~SHAREHOLDER~~SHAREHOLDERS’S DEFICIT

Preference shares — The Company is authorized to issue 5,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of ~~September~~March 3031, 2026 and December 31, 2025, there were no preference shares issued or outstanding.

Class A ordinary shares — The Company is authorized to issue 500,000,000 Class A ordinary shares with a par value of 0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of ~~September~~March 3031, 2026 and December 31, 2025, there were no Class A ordinary shares issued or outstanding, excluding the 17,250,000 shares subject to possible redemption.

Class B ordinary shares — The Company is authorized to issue 50,000,000 Class B ordinary shares with a par value of 0.0001 per share. Holders of the Company’s Class B ordinary shares are entitled to one vote for each share. As of ~~September~~March 3031, 2026 and December 31, 2025, there were 5,750,000 Class B ordinary shares ~~issued and~~ outstanding. Of the 5,750,000 Class B ordinary shares outstanding, up to 750,000 shares ~~are~~were subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the ~~Underwriters~~underwriters’ over-allotment option iswas not exercised in full or in part, so that the initial shareholders ~~will~~would collectively own 25% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. On December 12, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As a result, 750,000 Founder Shares are no longer subject to forfeiture by the Sponsor.

12Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Prior to the closing of the initial Business Combination, only holders of Class B ordinary shares (i) will have the right to appoint and remove directors prior to or in connection with the completion of the initial Business Combination and (ii) will be entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including any special resolution required to amend constitutional documents or to adopt new constitutional documents, in each case, as a result of approving a transfer by way of continuation to a jurisdiction outside the Cayman Islands). On any other matters submitted to a vote of shareholders prior to or in connection with the completion of the initial Business Combination, holders of the Class B ordinary shares and holders of the Class A ordinary shares will vote together as a single class, except as required by law.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

~~Ordinary~~ ~~shareholders~~The ofFounder ~~record~~Shares ~~are~~will ~~entitled~~automatically convert into Class A ordinary shares immediately prior to, ~~one~~concurrently ~~vote~~with ~~for~~or ~~each~~immediately ~~share~~following ~~held~~the onconsummation ~~all~~of ~~matters~~a toBusiness Combination, and may be ~~voted~~converted onat byany ~~shareholders.~~time ~~Except~~prior asto ~~described~~the ~~below~~Business Combination, ~~holders~~at the option of ~~Class A~~the ~~ordinary~~holder, ~~shares~~on ~~and~~a ~~holders~~one-for-one ofbasis ~~Class B~~(unless ~~ordinary~~otherwise ~~shares~~provided ~~will~~in ~~vote~~the ~~together~~Business asCombination aagreement), ~~single~~subject ~~class~~to onadjustment ~~all~~for ~~matters~~share ~~submitted~~subdivisions, toshare adividends, ~~vote~~reorganizations, ofrecapitalizations and the ~~Company’s~~like, ~~shareholders~~and ~~except~~subject asto ~~required~~further byadjustment ~~law.~~as ~~Prior~~provided toherein. In the ~~closing~~case ofthat ~~the~~additional ~~initial~~Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with the Business Combination, ~~only~~the ~~holders~~number of Class BA ordinary shares ~~(i) will~~issuable ~~have~~upon ~~the~~conversion ~~right~~of toall ~~appoint~~Founder ~~and~~Shares ~~remove~~will ~~directors~~equal, ~~prior~~in tothe oraggregate, inon ~~connection~~an ~~with~~as-converted ~~the~~basis, ~~completion~~approximately 25% of the ~~initial~~sum ~~Business~~of ~~Combination and~~ (iii) ~~will~~the betotal ~~entitled~~number toof ~~vote~~all onordinary ~~continuing~~shares ~~the~~outstanding ~~Company~~upon inthe acompletion ~~jurisdiction~~of ~~outside~~ the ~~Cayman~~Initial ~~Islands~~Public Offering (including any ~~special~~Class A ~~resolution~~ordinary ~~required~~shares issued pursuant to ~~amend~~the ~~constitutional~~underwriters’ ~~documents~~over-allotment oroption toand ~~adopt~~excluding ~~new~~the ~~constitutional~~Class A ~~documents,~~ordinary inshares ~~each~~underlying ~~case~~the Private Placement Warrants issued to the Sponsor and the underwriters), asplus a(ii) all ~~result~~Class A ofordinary ~~approving~~shares aand ~~transfer~~equity-linked bysecurities ~~way~~issued ofor ~~continuation~~deemed issued in aconnection ~~jurisdiction~~with ~~outside~~ the ~~Cayman~~initial ~~Islands).~~Business OnCombination (excluding any ~~other~~shares ~~matters~~or ~~submitted~~equity-linked tosecurities aissued, ~~vote~~or ofto ~~shareholders~~be ~~prior~~issued, to orany seller in ~~connection~~the ~~with~~initial Business Combination and any private placement-equivalent warrants issued to the ~~completion~~Sponsor or any of its affiliates or to the ~~initial~~Company’s ~~Business~~officers ~~Combination,~~and ~~holders~~directors upon conversion of ~~the~~working ~~Class B~~capital ~~ordinary~~loans) ~~shares~~minus ~~and~~(iii) any ~~holders~~redemptions of ~~the~~ Class A ordinary shares ~~will~~by ~~vote~~public ~~together~~shareholders asprior ato ~~single~~or ~~class,~~in ~~except~~connection aswith ~~required~~an byinitial ~~law~~Business Combination.

~~The Founder Shares will automatically convert into Class~~Warrants A— As ~~ordinary shares immediately prior to, concurrently with or immediately following the consummation~~ of aMarch ~~Business Combination~~31, 2026 and ~~may~~December ~~be converted at any time prior to the Business Combination~~31, ~~at the option of the holder~~2025, onthere awere ~~one-for-one basis (unless otherwise provided in the Business Combination agreement)~~10,250,000 ~~subject~~warrants ~~to adjustment for share subdivisions~~outstanding, ~~share~~including ~~dividends~~5, ~~reorganizations~~750,000 ~~recapitalizations~~of ~~and~~Public ~~the~~Warrants ~~like,~~ and ~~subject~~4,500,000 toof ~~further~~Private ~~adjustment~~Placement ~~as provided herein~~Warrants. InEach ~~the~~whole ~~case~~Public ~~that~~Warrant ~~additional~~entitles ~~Class A ordinary shares or equity-linked securities are issued or deemed issued in connection with~~ the ~~Business~~registered ~~Combination,~~holder ~~the~~to ~~number~~purchase ofone Class A ordinary ~~shares~~share ~~issuable~~at ~~upon~~a ~~conversion~~price of ~~all~~$11.50 ~~Founder~~per ~~Shares will equal~~share, insubject ~~the~~to ~~aggregate,~~adjustment ~~on an~~ as~~-converted~~ ~~basis~~discussed below, ~~approximately~~at ~~25%~~any oftime ~~the~~commencing ~~sum of (i)~~30 ~~the~~days ~~total~~after ~~number of all ordinary shares outstanding upon~~ the completion of the ~~Initial~~initial ~~Public~~Business ~~Offering~~Combination. ~~(including~~Pursuant ~~any Class A ordinary shares issued pursuant~~ to the ~~underwriters’~~warrant ~~over-allotment~~agreement, ~~option~~a ~~and~~warrant ~~excluding~~holder ~~the~~may ~~Class A~~exercise ~~ordinary~~its ~~shares~~Public ~~underlying the Private Placement~~ Warrants ~~issued~~only tofor ~~the~~a ~~Sponsor~~whole ~~and~~number ~~the~~of ~~Representative), plus (ii) all~~ Class A ordinary shares. ~~and~~No ~~equity-linked~~fractional ~~securities~~Public ~~issued~~Warrants orwill ~~deemed~~be issued inupon ~~connection~~separation ~~with~~of the ~~initial~~units ~~Business~~and ~~Combination~~only ~~(excluding~~whole ~~any~~Public ~~shares~~Warrants orwill ~~equity-linked~~trade. ~~securities~~The ~~issued,~~Public orWarrants towill beexpire ~~issued,~~five years toafter ~~any~~the ~~seller~~completion inof the initial Business Combination, ~~and~~at ~~any~~5:00 p.m., ~~private~~New York ~~placement-equivalent~~City ~~warrants~~time, ~~issued to the Sponsor~~ or ~~any~~earlier ~~of its affiliates or to the Company’s officers and directors~~ upon ~~conversion~~redemption ~~of working capital loans) minus (iii) any redemptions of Class A ordinary shares by public shareholders prior to~~ or ~~in connection with an initial Business Combination~~liquidation.

~~Warrants~~The Company has agreed that as soon as practicable, but in no event later than 20 —business Asdays after the closing of ~~September~~the ~~30,~~initial ~~2025~~Business Combination, ~~there~~the ~~were~~Company nowill ~~warrants~~use ~~issued~~commercially orreasonable ~~outstanding.~~efforts ~~Each~~to ~~whole~~file ~~Public~~with ~~Warrant~~the ~~entitles~~SEC ~~the~~a ~~registered~~post-effective ~~holder~~amendment to ~~purchase~~the ~~one~~registration ~~Class A~~statement ~~ordinary~~filed ~~share~~in atconnection awith ~~price~~the ofInitial ~~$11.50~~Public ~~per~~Offering ~~share,~~or ~~subject~~a tonew ~~adjustment~~registration asstatement ~~discussed~~covering ~~below~~the registration, atunder ~~any~~the ~~time~~Securities ~~commencing~~Act, 30of the Class ~~days~~A ~~after~~ordinary ~~the~~shares ~~completion~~issuable upon exercise of the ~~initial~~warrants ~~Business~~and ~~Combination.~~thereafter ~~Pursuant~~will use the Company’s commercially reasonable efforts to cause the ~~warrant~~same ~~agreement,~~to abecome ~~warrant~~effective ~~holder~~within ~~may~~60 business days ~~exercise~~following ~~its~~the ~~Public~~initial ~~Warrants~~Business ~~only~~Combination ~~for~~and to maintain a ~~whole~~current ~~number~~prospectus ofrelating to the Class A ordinary shares. Noissuable ~~fractional~~upon ~~Public~~exercise ~~Warrants~~of ~~will~~the bewarrants, ~~issued~~until ~~upon~~the ~~separation~~expiration of the ~~units~~warrants ~~and~~in ~~only~~accordance ~~whole~~with ~~Public~~the ~~Warrants~~provisions ~~will~~of ~~trade~~the warrant agreement. ~~The~~If ~~Public~~a ~~Warrants~~registration ~~will~~statement ~~expire~~covering ~~five~~the Class ~~years~~A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60) business day after the ~~completion~~closing of the initial Business Combination, atwarrant ~~5:00 p.m.~~holders may, ~~New York~~until ~~City~~such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, orexercise ~~earlier~~warrants ~~upon~~on ~~redemption~~a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or ~~liquidation~~another exemption.

Once ~~The Company has agreed that as soon as practicable, but in no event later than 20 business days after~~ the closing of the initial Business Combination, the Company will use commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement of which this prospectus forms a part or a new registration statement covering the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants ~~and thereafter will use the Company’s commercially reasonable efforts to cause the same to~~ become ~~effective within 60 business days following the initial Business Combination and to maintain a current prospectus relating to the Class A ordinary shares issuable upon exercise of the warrants~~exercisable, ~~until~~ the ~~expiration~~Company of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60) business day after the closing of the initial Business Combination, warrant holders may, ~~until~~call ~~such time as there is an effective registration statement and during any period when~~ the ~~Company will have failed to maintain an effective registration statement, exercise~~ warrants onfor aredemption ~~“cashless~~for ~~basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption.~~ cash:

Once the warrant becomes exercisable, the Company may call the warrants for redemption for cash:

●

in whole and not in part;

●

at a price of $0.01 per warrant;

●

upon a minimum of 30 days’ prior written notice of redemption;

●

if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “Warrants”) for any 20 trading days within a 30-trading day period commencing at least 30 days after completion of the Company’s initial Business Combination and ending three business days before the Company sends the notice of redemption to the warrant holders.

13If and when the warrants become redeemable by the Company for cash, the Company may exercise the redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

If ~~and~~In ~~when~~addition, if (x) the ~~warrants~~Company ~~become~~issues ~~redeemable~~additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary shares (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares or Private Placement Shares held by the initial shareholders or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for ~~cash~~the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the ~~Company~~volume ~~may~~weighted ~~exercise~~average trading price of the ~~redemption~~Class A ~~right~~ordinary ~~even~~shares ifduring the 20 trading day period starting on the trading day after the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is ~~unable~~below $9.20 per share, the exercise price of the warrants will be adjusted (to ~~register~~the ornearest ~~qualify~~cent) to be equal to 115% of the ~~underlying~~higher ~~securities~~of ~~for~~the ~~sale~~Market ~~under~~Value ~~all~~and ~~applicable~~the ~~state~~Newly ~~securities~~Issued ~~laws~~Price, and the $18.00 per-share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

InThe ~~addition,~~Private ifPlacement Warrants (~~x) the~~including ~~Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with~~ the ~~closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per~~ Class A ordinary shares ~~(with~~issuable ~~such~~upon ~~issue~~exercise ~~price or effective issue price to be determined in good faith by the Company’s board~~ of ~~directors and, in~~ the ~~case of any such issuance to the initial shareholders or their affiliates, without taking into account any Founder Shares or~~ Private Placement Warrants ~~held by the initial shareholders or such affiliates, as applicable, prior to such issuance~~) ~~(the~~will ~~“Newly~~not ~~Issued~~be ~~Price”)~~transferable, ~~(y) the~~assignable ~~aggregate~~or ~~gross~~salable ~~proceeds~~until from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z)30 ~~the~~days ~~volume weighted average trading price of the Class A ordinary shares during the 20 trading day period starting on the trading day~~ after the ~~day~~ oncompletion ~~which~~of the ~~Company consummate the~~ initial Business Combination ~~(such price, the “Market Value”) is below $9~~.20 ~~per~~The ~~share,~~Private ~~the~~Placement ~~exercise~~Warrants ~~price~~have ofterms ~~the~~and ~~warrants~~provisions ~~will~~that beare ~~adjusted~~identical (to ~~the~~those ~~nearest cent) to be equal to 115%~~ of the ~~higher~~Public ofWarrants ~~the~~being ~~Market~~sold ~~Value~~as ~~and~~part ~~the Newly Issued Price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180%~~ of the ~~higher~~units ofin the ~~Market~~Initial ~~Value~~Public ~~and the Newly Issued Price~~Offering.

The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination. The Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants being sold as part of the Units in the Initial Public Offering.

NOTE 8. SEGMENT INFORMATION

FASB ASC Topic 280, Segment Reporting, establishes standards for companies to report in their financial statements information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by the Company’s chief operating decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.

The Company’s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company only has one reporting segment.

The CODM assesses performance for the single segment and decides how to allocate resources based on net income or loss, ~~that~~which ~~also~~ is ~~reported~~presented on the unaudited condensed statement of operations as net income or loss. The measure of segment assets is reported on the ~~unaudited~~ condensed balance ~~sheet~~sheets as total assets. When evaluating the Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include the following:

	As of September 30, 2025
	March 31,		December 31,
Cash	$	249,101
	2026		2025
Deferred offering costs	$	322,564
Cash	$	497,651	$	693,561
Cash and marketable securities held in Trust Account	$	174,208,247	$	172,738,674

	For the Period from July 11, 2025 (Inception) through September 30, 2025
	For the Three Months Ended March 31, 2026
General and administrative costs	$	49208,~~503~~752
Interest earned on cash and marketable securities held in Trust Account	$	1,469,573

14The CODM reviews general and administrative costs to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period. The CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the unaudited condensed statement of operations, are the significant segment expenses provided to the CODM on a regular basis.

The CODM reviews the position of total assets as reported in the Company’s condensed balance sheets to assess if the Company has sufficient resources available to discharge its liabilities. The CODM is provided with details of cash and liquid resources available with the Company.

BLUEROCK ACQUISITION CORP.

NOTES TO CONDENSED FINANCIAL STATEMENTS

~~SEPTEMBER~~MARCH 3031, ~~2025~~2026

(UNAUDITED)

~~The~~NOTE CODM reviews general and administrative costs to manage and forecast cash to ensure enough capital is available to complete a Business Combination or similar transaction within the Business Combination period9. ~~The~~FAIR ~~CODM~~VALUE also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. General and administrative costs, as reported on the unaudited condensed statement of operations, are the significant segment expenses provided to the CODM on a regular basis.MEASUREMENTS

~~The~~Fair ~~CODM~~value ~~reviews~~is defined as the ~~position~~price ofthat ~~total~~would ~~assets~~be asreceived ~~reported~~for insale ~~the~~of ~~Company’s~~an ~~unaudited~~asset ~~condensed~~or ~~balance~~paid ~~sheet~~for totransfer ~~assess~~of ifa ~~the~~liability ~~Company~~in ~~has~~an ~~sufficient~~orderly ~~resources~~transaction ~~available~~between tomarket ~~discharge~~participants ~~its~~at ~~liabilities~~the measurement date. ~~The~~GAAP ~~CODM~~establishes isa ~~provided~~three-tier ~~with~~fair ~~details~~value ofhierarchy, ~~cash~~which ~~and~~prioritizes ~~liquid~~the ~~resources~~inputs ~~available~~used ~~with~~in ~~the~~measuring ~~Company~~fair value. ~~Additionally,~~The hierarchy gives the ~~CODM~~highest ~~regularly~~priority ~~reviews~~to ~~the~~unadjusted ~~status~~quoted ofprices ~~deferred~~in ~~costs~~active ~~incurred~~markets tofor ~~assess~~identical ifassets ~~these~~or ~~are~~liabilities in(Level ~~line~~1 ~~with~~measurements) and the ~~planned~~lowest ~~use~~priority ofto ~~proceeds~~unobservable ~~raised~~inputs ~~from~~(Level ~~the~~3 ~~Initial~~measurements). ~~Public~~These ~~Offering.~~tiers include:

~~NOTE~~● 9.Level ~~SUBSEQUENT~~1, ~~EVENTS~~ defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

~~The~~● ~~Company~~Level ~~evaluated~~2, ~~subsequent~~defined ~~events~~as ~~and~~inputs ~~transactions~~other ~~that~~than ~~occurred~~quoted ~~after~~prices ~~the~~in ~~unaudited~~active ~~condensed~~markets ~~balance sheet date up to January 26, 2026, the date~~ that ~~the~~are ~~unaudited~~either ~~condensed~~directly ~~financial~~or ~~statements~~indirectly ~~were~~observable ~~issued.~~such ~~Based upon this review, other than~~ as ~~described~~quoted ~~below,~~prices ~~the~~for ~~Company~~similar ~~did~~instruments ~~not~~in ~~identify~~active ~~any~~markets ~~subsequent~~or ~~events~~quoted ~~that~~prices ~~would~~for ~~have~~identical ~~required adjustment~~ or ~~disclosure~~similar instruments in ~~the~~markets ~~unaudited~~that ~~condensed~~are ~~financial~~not ~~statements.~~active; and

● OnLevel ~~October 1~~3, ~~2025,~~defined ~~the~~as ~~Sponsor~~unobservable ~~surrendered~~inputs 1in which little or no market data exists,~~916,667~~ ~~Founder~~therefore ~~Shares~~requiring toan ~~the~~entity ~~Company~~to ~~for~~develop noits ~~consideration~~own assumptions, ~~resulting~~such inas ~~the~~valuations ~~Sponsor~~derived ~~holding~~from ~~5,750,000~~valuation ~~Founder~~techniques ~~Shares.~~in ~~All~~which ~~share~~one ~~and~~or ~~per~~more ~~share~~significant ~~data~~inputs ~~has~~or ~~been~~significant ~~retrospectively~~value ~~presented.~~drivers are unobservable.

The Onfollowing ~~October~~table ~~29,~~presents ~~2025,~~information about the ~~Sponsor~~Company’s ~~transferred~~assets ~~60,000~~that ~~Founder~~are ~~Shares~~measured toat ~~the~~fair ~~independent~~value ~~directors~~as inof ~~exchange~~March ~~for~~31, ~~their~~2026 ~~services~~and asDecember ~~independent~~31, ~~directors~~2025 ~~through~~and indicates the ~~Company’s~~fair ~~initial~~value ~~Business~~hierarchy ~~Combination,~~of ~~resulting in~~ the ~~Sponsor~~valuation ~~holding~~inputs ~~5,690,000~~the ofCompany ~~the~~utilized ~~total~~to ~~5,750,000~~determine ~~Founder~~such ~~Shares.~~fair value:

Description	Level	March 31, 2026		December 31, 2025
Assets:
Marketable securities held in Trust Account	1	$	174,208,247	$	172,738,674

In ~~The~~some ~~registration~~circumstances, ~~statement for~~ the ~~Company’s~~inputs ~~Initial~~used ~~Public~~to ~~Offering~~measure ~~became~~fair ~~effective~~value onmight ~~December~~be ~~10,~~categorized ~~2025.~~within Ondifferent ~~December~~levels ~~12,~~of ~~2025,~~ the ~~Company~~fair ~~consummated~~value ~~the~~hierarchy. ~~Initial~~In ~~Public~~those ~~Offering~~instances, ofthe ~~17,250,000~~fair ~~Units,~~value ~~which~~measurement ~~includes~~is ~~the~~categorized ~~full~~in ~~exercise~~its byentirety in the ~~underwriters~~fair ofvalue ~~their~~hierarchy ~~over-allotment~~based ~~option~~on ofthe ~~2,250,000~~lowest ~~Units,~~level atinput ~~$10.00~~that ~~per~~is ~~Unit,~~significant ~~generating~~to ~~gross~~the ~~proceeds~~fair ofvalue ~~$172,500,000~~measurement.

~~Simultaneously~~The ~~with~~fair ~~the~~value ~~closing~~ of the ~~Initial~~ Public ~~Offering~~Warrants onis ~~December 12~~$2, ~~2025~~254,000 ~~the~~or ~~Company~~$0.39 ~~consummated~~per ~~the~~Public ~~sale~~Warrant. ofThe anfair ~~aggregate~~value of ~~4,500,000~~Public ~~warrants,~~Warrants atwas adetermined ~~price~~using ofMonte ~~$1.00~~Carlo ~~per~~Simulation ~~Private~~Model. ~~Placement~~The ~~Warrant,~~Public inWarrants ahave ~~private~~been ~~placement~~classified towithin ~~the~~shareholders’ ~~Sponsor~~deficit and ~~the~~will ~~Representative,~~not ~~generating~~require ~~gross~~remeasurement ~~proceeds~~after ~~of $4,500,000~~issuance. OfThe ~~those~~following ~~4,500,000~~table ~~Private~~presents ~~Placement Warrants,~~ the ~~Sponsor~~quantitative ~~purchased~~information ~~3,000,000~~regarding ~~Private~~market ~~Placement~~assumptions ~~Warrants~~used ~~and~~in the ~~Representative~~Level ~~purchased~~3 ~~1,500,000~~valuation ~~Private~~of ~~Placement~~the Public Warrants.:

	December 12, 2025
Underlying stock price	$	9.86
Exercise price	$	11.50
Volatility		5.0	%
Remaining term (years)		7.00
Risk-free rate		3.87	%
Implied market adjustment		32.3	%

NOTE ~~On December 12, 2025, the underwriters were paid in cash an underwriting discount of $3,000,000 simultaneously at the closing of the Initial Public Offering~~10. InSUBSEQUENT ~~addition, the underwriters were entitled to a deferred fee of $0.60 per Unit, $7,350,000 in the aggregate.~~ EVENTS

The OnCompany ~~December~~evaluated ~~12,~~subsequent ~~2025,~~events and transactions that occurred after the ~~Company~~condensed ~~fully~~balance ~~settled~~sheet date up to the ~~$300~~date that the unaudited condensed financial statements were issued. Based upon this review,~~000~~ ~~outstanding~~the ~~balance~~Company ofdid not identify any subsequent events that would have required adjustment or disclosure in the ~~Promissory~~unaudited ~~Note.~~condensed financial statements.

1516

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Bluerock Acquisition Corp. References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Bluerock Acquisition Holdings LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Special Note Regarding Forward-Looking Statements

This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the completion of the Proposed Business Combination (as defined below), the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements, including that the conditions of the Proposed Business Combination are not satisfied. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s ~~final~~Annual ~~prospectus~~ Report on Form 10K for ~~its~~the ~~Initial~~period ~~Public~~from ~~Offering~~July 11, 2025 (inception) to December 31, 2025, filed with the U.S. Securities and Exchange Commission (the “SEC”) (such report, the “Annual Report”). The Company’s ~~securities~~ securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable ~~securities~~ securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Overview

We are a blank check company incorporated in the Cayman Islands on July 11, 2025. We are formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or ~~other~~ similar ~~Business~~business ~~Combination~~combination with one or more businesses. We ~~intend~~may pursue toan ~~effectuate~~initial ~~our~~ Business Combination ~~using~~ ~~cash~~in ~~derived~~any ~~from~~business ~~the proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, our shares, debt~~ or a ~~combination of cash, shares and debt~~industry.

We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.

Results of Operations

We have neither engaged in any operations nor generated any revenues to date. Our only activities from July 11, 2025 (inception) through March ~~September 30~~31, ~~2025~~2026 were organizational activities, and those necessary to prepare for the Initial Public Offering, described below, and identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. ~~Subsequent~~We ~~to the Initial Public Offering, we~~ generate non-operating income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses.

For the ~~period~~three ~~from~~months ~~July 11, 2025 (inception)~~ended ~~through~~March ~~September 30~~31, ~~2025~~2026, we had a net ~~loss~~income of $491,~~503~~260,821, which consisted of ~~general~~interest earned on cash and ~~administrative~~marketable securities held in Trust Account of $1,469,573, partially offset by operating costs of $208,752.

Liquidity and Capital Resources

~~Until~~On December ~~the~~12, ~~consummation~~2025, ofwe consummated the Initial Public Offering of 17,250,000 Units, which includes the exercise by the underwriters of ~~our~~their ~~only~~over-allotment ~~source~~option in full of ~~liquidity~~2,250,000 ~~was~~Units, anat ~~initial~~$10.00 ~~purchase~~per Unit, generating gross proceeds of ~~Class B~~$172,500,000. ~~ordinary~~Simultaneously with ~~shares~~the closing of the Initial Public Offering, ~~par~~we ~~value~~consummated the sale of an aggregate of 4,500,000 Private Placement Warrants at a price of $01.~~0001~~00 per ~~share~~Private Placement Warrant, byin a private placement to the Sponsor and ~~loans~~ ~~from~~Cantor, as representative of the ~~Sponsor~~underwriters, generating gross proceeds of $4,500,000.

Subsequent to the quarterly period covered by this Quarterly Report on Form 10-Q, on December 12, 2025, we consummated the Initial Public Offering of 17,250,000 Units, which includes the exercise by the underwriters of their over-allotment option in full of 2,250,000 Units, at $10.00 per Unit, generating gross proceeds of $172,500,000. Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 4,500,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, in a private placement to the Sponsor and the Representative, generating gross proceeds of $4,500,000.

Following the Initial Public Offering, the exercise of the over-allotment option in full, and the sale of the Units, a total of $230,000,000 was placed in the Trust Account. We incurred transaction costs amounting to $10,960,469, consisting of $3,000,000 of cash underwriting fee, $7,350,000 of deferred underwriting fee and $610,469 of other offering costs.

For the period from July 11, 2025 (inception) through September 30, 2025, net cash used in operating activities was nil. Net loss of $49,503 was affected by payment of general and administrative costs through promissory note – related party of $42,900 and changes in accrued expenses of $6,603.

We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less income taxes payable), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into Warrants, at a price of $1.00 per warrant at the option of the lender, upon consummation of the initial Business Combination. The Warrants would be identical to the Private Placement Warrants.

We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our Public Shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Off-Balance Sheet Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of September 30, 2025. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual obligations

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to an affiliate of the Sponsor $20,000 per month for office space, utilities and secretarial and administrative support services provided to members of the management team.

The Company granted the underwriters a 45-day option from the date of the Initial Public Offering to purchase up to 2,250,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On December 12, 2025, the underwriters exercised their over-allotment option, closing on the 2,250,000 additional units simultaneously with the Initial Public Offering.

The underwriters were paid in cash an underwriting discount of $3,000,000 upon the closing of the Initial Public Offering on December 12, 2025. In addition, the underwriters are entitled to a deferred fee of $0.60 per Unit, or $7,350,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination.

Critical Accounting Estimates

The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Making estimates requires management to exercise significant judgement. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could materially differ from those estimates. As of September 30, 2025, we did not have any critical accounting estimates to be disclosed.

Following the Initial Public Offering, the exercise of the over-allotment option in full, and the sale of the Private Placement Warrants, a total of $172,500,000 was placed in the Trust Account. We incurred $10,960,469 in IPO related costs, consisting of $3,000,000 of cash underwriting fees, $7,350,000 of deferred underwriting fees, and $610,469 of other costs.

For the three months ended March 31, 2026, cash used in operating activities was $195,910. Net income of $1,260,821 was offset by Interest earned on marketable securities held in Trust Account of $1,469,573, and changes in operating assets and liabilities, which provided $12,842 of cash for operating activities.

As of March 31, 2026, we had cash held in the Trust Account of $174,208,247, consisting of U.S. Treasury Bills with a maturity of 185 days or less. We may withdraw interest from the Trust Account as described above. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing earnings on the Trust Account (less taxes payable, if any), to complete our Business Combination. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.

As of March 31, 2026, we had $497,651 cash and a working capital surplus of $509,650. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.

In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor, or certain of our officers and directors or their affiliates may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such working capital loans may be convertible into private placement warrants of the post-Business Combination entity, at a price of $1.00 per warrant at the option of the lender, upon consummation of the initial Business Combination. The warrants would be identical to the Private Placement Warrants.

obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination.

Off-Balance Sheet Financing Arrangements

We have no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2026. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.

Contractual Obligations

Administrative Services and Indemnification Agreement

We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor up to $20,000 per month for a maximum of twelve months during the Completion Window for office space, secretarial and administrative services.

The Company agreed to indemnify and hold harmless the Sponsor and its directors, officers, employees, principals, managers, partners, members, shareholders, equity holders, control persons, affiliates, agents, advisors, consultants and representatives (the “Indemnitees”) from any claims, losses, liabilities, obligations, causes of action, proceedings (whether pending or threatened), investigations, damages, awards, settlements, judgments, decrees, fees, costs, penalties, amounts paid in settlement or expenses (including interest, assessments and other charges in connection therewith and reasonable fees and disbursements of attorneys and other professional advisors and costs of suit) arising out of or relating to any pending or threatened claim, action, suit, proceeding or investigation against any of them or in which any of them may be a participant or may otherwise be involved (including as a witness) that arises out of or relates to (i) the IPO of the Company’s securities or the Company’s operations or conduct of its business (including, for the avoidance of doubt, a Business Combination), or (ii) any claim against the Sponsor alleging any expressed or implied management or endorsement by the Sponsor of any activities of the Company or any express or implied association between the Sponsor, on the one hand, and the Company or any of its affiliates, on the other hand.

Underwriting Agreement

The underwriters received a cash underwriting discount of $0.20 per Unit sold in the IPO, or $3,000,000 in the aggregate. In addition, the underwriters are entitled to a deferred fee of $0.40 per Unit, or $7,350,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, but such $0.40 per Unit shall be due to the underwriters solely on amounts remaining in the Trust Account following all properly submitted shareholder redemptions, including in connection with the consummation of the Company’s initial Business Combination, subject to the terms of the underwriting agreement.

Registration Rights Agreement

The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the Initial Public Offering, (ii) Private Placement Warrants, which were issued in a private placement simultaneously with the closing the Initial Public Offering and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of working capital loans, have registration rights to require us to register a sale of any of our securities that they hold, including any securities acquired prior to the consummation of our initial Business Combination, pursuant to a registration rights agreement signed on the effective date of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain piggyback registration rights with respect to registration statements filed subsequent to our completion of our initial Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Critical Accounting Estimates

Ordinary Shares Subject to Possible Redemption

We account for our ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including common stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified in temporary equity. At all other times, ordinary shares are classified as stockholders’ equity. Our Public Shares feature certain redemption rights that are considered to be outside of our control and subject to occurrence of uncertain future events. Accordingly, as of March 31, 2026, the Public Shares are presented at redemption value as temporary equity, outside of the shareholders’ equity (deficit) section of our balance sheet. We recognize changes in redemption value immediately as they occur and adjusts the carrying value of the ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security.

Recent Accounting Standards

Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

~~Not~~We ~~required~~are ~~for~~a smaller reporting company ~~companies~~as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended, and are not required to provide the information otherwise required under this item.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer (together, the “Certifying Officers”), or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure.

Under the supervision and with the participation of our Management, including our Certifying Officers, we carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on the foregoing, our Certifying Officers concluded that our disclosure controls and procedures were effective as of the end of the quarterly period ended ~~September~~ 30March 31, ~~2025~~2026.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter of ~~2025~~2026 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

1820

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None

Item 1A. Risk Factors

Factors that could cause our actual results to differ materially from those in this report include the risk factors described in our ~~final~~Annual ~~prospectus~~Report ~~for~~on ~~its~~Form ~~Initial~~10K ~~Public Offering~~ filed with the SEC. As of the date of this Report, there have been no material changes to the risk factors disclosed in our ~~final~~Annual ~~prospectus for~~Report ~~its~~on ~~Initial~~Form ~~Public~~10K ~~Offering~~ filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

~~On July 23, 2025, the Sponsor was issued 7,666,667 Founder Shares for an aggregate price of $25,000, or approximately $0~~None.003 per share, paid to cover certain expenses on behalf of the Company. On October 1, 2025, the Sponsor surrendered 1,916,667 Founder Shares to the Company for no consideration, resulting in the Sponsor holding 5,750,000 Founder Shares. All share and per share data has been retrospectively presented. On October 29, 2025, the Sponsor transferred 60,000 Founder Shares to the independent directors in exchange for their services as independent directors through the Company’s initial Business Combination, resulting in the Sponsor holding 5,690,000 of the total 5,750,000 Founder Shares. The issuance of the Founder Shares to the Sponsor was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 4,500,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, in a private placement to the Sponsor and the Representative, generating gross proceeds of $4,500,000. Of those 4,500,000 Private Placement Warrants, the Sponsor purchased 3,000,000 Private Placement Warrants and the Representative purchased 1,500,000 Private Placement Warrants. The sale of the Private Placement Warrants was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

The Private Placement Warrants are identical to the warrants underlying the Units sold in the Initial Public Offering, except that the Private Placement Warrants are not transferable, assignable or salable until after the completion of a Business Combination, subject to certain limited exceptions.

Of the gross proceeds received from the Initial Public Offering and the proceeds of the sale of the Private Placement Warrants, an aggregate of $172,500,000 was placed in the Trust Account.

We paid a total transaction costs of $10,960,469, consisting of $3,000,000 of cash underwriting fee, $7,350,000 of deferred underwriting fee and $610,469 of other offering costs.

For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Form 10-Q.

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

None

Item 5. Other Information

None

Item 6. Exhibits

The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.

No.		Description of Exhibit
1.1		Underwriting Agreement, dated December 10, 2025, by and between the Company and the Representative (incorporated by reference to Exhibit 1.1 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
3.1		Second Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
4.1		Warrant Agreement, dated December 10, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.1		Letter Agreement, dated December 10, 2025, by and among the Company, its executive officers, its directors and the Sponsor (incorporated by reference to Exhibit 10.1 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.2		Investment Management Trust Agreement, dated December 10, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.2 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.3		Registration Rights Agreement, dated December 10, 2025, by and among the Company, the Sponsor and the Holders signatory thereto (incorporated by reference to Exhibit 10.3 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.4		Private Placement Warrants Purchase Agreement, dated December 10, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.4 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.5		Private Placement Warrants Purchase Agreement, dated December 10, 2025, by and between the Company and the Representative (incorporated by reference to Exhibit 10.5 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
10.6		Administrative Services and Indemnification Agreement, dated December 10, 2025, by and between the Company and the Sponsor (incorporated by reference to Exhibit 10.6 of the Company’s Form 8-K (File No. 001-43007), filed with the SEC on December 16, 2025).
31.1*		Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*		Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**		Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**		Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS		Inline XBRL Instance Document.
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

2021

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	BLUEROCK ACQUISITION CORP.
Date: January 26, 2026	By:	/s/ R. Ramin Kamfar
Date: May 14, 2026	By:	/s/ R. Ramin Kamfar
	Name:	R. Ramin Kamfar
	Title:	Chief Executive Officer and Co-Chairman
		(Principal Executive Officer)
Date: January 26, 2026	By:	/s/ Christopher Vohs
Date: May 14, 2026	By:	/s/ Christopher Vohs
	Name:	Christopher Vohs
	Title:	Chief Financial Officer
		(Principal Financial and Accounting Officer)

2122

Filing Compare · Bluerock Acquisition Corp.